Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children born

By Ludwig M   Katalinic A   Felberbaum RE   Diedrich K  

Reproductive BioMedicine Online, Vol. 5, Iss. 3, 2002-11 ,pp. : 61-67

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Substituting HCG with GnRH agonist to trigger final follicular maturation – a retrospective comparison of three different ovarian stimulation protocols

By Orvieto Raoul   Rabinson Jacob   Meltzer Simion   Zohav Efraim   Anteby Eyal   Homburg Roy  

Reproductive BioMedicine Online, Vol. 13, Iss. 2, 2006-08 ,pp. : 198-201

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Reluctance of medical professionals in adopting natural-cycle and minimal ovarian stimulation protocols in human clinical assisted reproduction

By Heng Boon Chin  

Reproductive BioMedicine Online, Vol. 15, Iss. 1, 2007-07 ,pp. : 9-11

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

GnRH antagonists in ovarian stimulation for ICSI with oocyte restriction: a matched, controlled study

By Greco E   Litwicka K   Ferrero S   Baroni E   Sapienza F   Rienzi L   Romano S   Minasi MG   Tesarik J  

Reproductive BioMedicine Online, Vol. 14, Iss. 5, 2007-05 ,pp. : 572-578

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis

By Griesinger G   Diedrich K   Tarlatzis BC   Kolibianakis EM  

Reproductive BioMedicine Online, Vol. 13, Iss. 5, 2006-11 ,pp. : 628-638

Reproductive Healthcare Ltd

Access to resources Recommend Favorite